Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02030418 · ClinicalTrials.gov registry record · NA
The LEADLESS II IDE Study for the Nanostim Leadless Pacemaker
A NA study, sponsored by Abbott Medical Devices.
- Completed
- Registry status
- NA
- Development phase
- 952
- Enrollment target
NCT02030418 is a NA study that has completed, run by Abbott Medical Devices. The registered enrollment target is 952 participants.
The verdict
NCT02030418, a NA study, has completed, sponsored by Abbott Medical Devices.
- COMPLETED
- Registry status
- NA
- Development phase
- 952 participants
- Enrollment target
Study Summary
Prospective, non-randomized, single-arm, international multicenter, clinical safety and effectiveness of a leadless pacemaker system in patients who are indicated for a VVIR pacemaker. Following completion of enrollments in the IDE, patients will continue to be enrolled in the continued access phase of the study under the same protocol.
Interventions
- DEVICE Leadless Pacemaker
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 952 participants |
| Start Date | 2014-02 |
| Est. Completion | 2022-07-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02030418
The ClinicalTrials.gov registry entry for NCT02030418 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 952 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abbott Medical Devices, which has 261 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Leadless Pacemaker is the first listed.
NCT02030418 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02030418 about?
NCT02030418 is a clinical study titled "The LEADLESS II IDE Study for the Nanostim Leadless Pacemaker". Prospective, non-randomized, single-arm, international multicenter, clinical safety and effectiveness of a leadless pacemaker system in patients who are indicated for a VVIR pacemaker. Following completion of enrollments in the IDE, patients will continue to be enrolled in the continued access phas...
What is the current status of trial NCT02030418?
This trial is currently completed. It is a NA study. The enrollment target is 952 participants. The study started on 2014-02. Estimated completion is 2022-07-15.
What interventions are being tested in trial NCT02030418?
The interventions under investigation include: Leadless Pacemaker (DEVICE).
Who is sponsoring clinical trial NCT02030418?
This trial is sponsored by Abbott Medical Devices, which has 261 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.